Industry Newsbinx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19
Industry NewsPfizer and BioNTech receive Emergency Use Authorization for COVID-19 vaccine in adolescents
Industry NewsRapid evolution and host immunity drive the rise and fall of antibiotic resistance during acute infection
Industry NewsSingle dose of Pfizer-BioNTech or Oxford-AstraZenca vaccine reduces infection rate by 65%, study finds
Industry NewsOxford University and Prenetics announce landmark collaboration to scale rapid testing tech globally
Industry NewsPrior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Industry NewsSeven in ten patients hospitalized with COVID-19 not fully recovered five months after discharge
Industry NewsAbility of multi-drug resistant infection to evolve within cystic fibrosis patients highlights need for rapid treatment
Industry NewsIllumina and Kartos Therapeutics partner to develop an NGS-based TP53 companion diagnostic
Editorial ArticleTargeting protein-protein interactions (PPIs): Identifying PPI inhibitors for novel therapeutics